Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic-Reference-Cited by-同舟云学术

Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic

Published:2023-04-05 Issue:1 Volume:12 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Alvarez Maite¹²³^ORCID,Molina Carmen¹²,Garasa Saray¹²,Ochoa Maria C.¹²³,Rodriguez-Ruiz Maria E⁴,Gomis Gabriel¹²,Cirella Assunta¹²,Olivera Irene¹²,Glez-Vaz Javier¹²,Gonzalez-Gomariz Jose¹²,luri-Rey carlos¹²,azpilikueta arantza¹²,Bolaños Elixabet¹²,Teijeira Alvaro¹²³,Berraondo Pedro¹²³,Quintero Marisol⁵,Melero Ignacio¹²³⁴⁶^ORCID

Affiliation:

1. Program for Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain

2. Navarra Institute for Health Research (IdiSNA), Pamplona, Spain

3. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain

4. Departments of Immunology and Oncology (CCUN), Clínica Universidad de Navarra, Pamplona, Spain

5. Highlight Therapeutics, Valencia, Spain

6. Nuffield Department of Medicine and Oxford Center for Immuno-Oncology, University of Oxford, Oxford, UK

Funder

Instituto de Salud Carlos III

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2023.2197370

Reference27 articles.

1. Intratumoural administration and tumour tissue targeting of cancer immunotherapies

2. Intratumoral Immunotherapy for Early-stage Solid Tumors

3. Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma

4. Idera pharmaceuticals announces results from illuminate-301 trial of tilsotolimod + ipilimumab in anti-PD-1 refractory advanced melanoma;Conwell J;Aceragen,2021

5. Making the Most of Cancer Surgery with Neoadjuvant Immunotherapy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C;Journal for ImmunoTherapy of Cancer;2024-04

2. Decoding Toll-like receptors: Recent insights and perspectives in innate immunity;Immunity;2024-04

3. Harnessing innate immune pathways for therapeutic advancement in cancer;Signal Transduction and Targeted Therapy;2024-03-25

4. Dendritic cells as orchestrators of anticancer immunity and immunotherapy;Nature Reviews Clinical Oncology;2024-02-07

5. Polymeric nanocapsules loaded with poly(I:C) and resiquimod to reprogram tumor-associated macrophages for the treatment of solid tumors;Frontiers in Immunology;2024-01-08